Published in Psychopharmacology (Berl) on August 01, 2001
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. Psychopharmacology (Berl) (2003) 1.66
Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berl) (2003) 1.59
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br J Pharmacol (2007) 1.47
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol (2008) 1.41
Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev (2014) 1.37
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Neuropharmacology (2007) 1.35
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? Life Sci (2013) 1.28
Do initial responses to drugs predict future use or abuse? Neurosci Biobehav Rev (2012) 1.26
Baths salts, spice, and related designer drugs: the science behind the headlines. J Neurosci (2014) 1.14
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers. Psychopharmacology (Berl) (2010) 1.11
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br J Pharmacol (2004) 1.08
Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol Res (2007) 1.07
Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A (2003) 1.05
Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones. Br J Pharmacol (2010) 1.03
Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci (2016) 1.01
Self-administration of cannabinoids by experimental animals and human marijuana smokers. Pharmacol Biochem Behav (2005) 1.01
Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int Rev Psychiatry (2009) 0.98
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. Psychopharmacology (Berl) (2004) 0.96
Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration. Psychopharmacology (Berl) (2006) 0.96
Harm reduction--the cannabis paradox. Harm Reduct J (2005) 0.94
Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future. Front Psychiatry (2014) 0.93
Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacol Ther (2013) 0.92
Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model. Pharmacol Biochem Behav (2014) 0.90
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection. Pharmacol Biochem Behav (2014) 0.89
Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder. Psychopharmacology (Berl) (2009) 0.88
Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. Psychopharmacology (Berl) (2006) 0.86
3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism. J Pharmacol Exp Ther (2011) 0.86
Role of the endocannabinoid system in MDMA intracerebral self-administration in rats. Br J Pharmacol (2002) 0.85
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies. Front Pharmacol (2015) 0.85
Animal models of cannabinoid reward. Br J Pharmacol (2010) 0.84
Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice. Br J Pharmacol (2004) 0.84
The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding. Eur J Pharmacol (2007) 0.84
Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. Curr Addict Rep (2014) 0.83
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci (2013) 0.82
Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats. Neuropsychopharmacology (2015) 0.81
Drug addiction. Curr Top Behav Neurosci (2009) 0.81
The CB1 receptor antagonist AM251 impairs reconsolidation of pavlovian fear memory in the rat basolateral amygdala. Neuropsychopharmacology (2014) 0.80
Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat. J Addict Res Ther (2011) 0.80
Modulation of the endocannabinoid system: therapeutic potential against cocaine dependence. Pharmacol Res (2007) 0.80
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. Br J Pharmacol (2011) 0.80
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling. Neuropsychopharmacology (2017) 0.78
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure. Neuropsychopharmacology (2017) 0.78
Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg. Psychopharmacology (Berl) (2016) 0.78
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms. Front Pharmacol (2014) 0.78
Synthetic Pot: Not Your Grandfather's Marijuana. Trends Pharmacol Sci (2017) 0.78
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. Psychopharmacology (Berl) (2012) 0.77
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat. Psychopharmacology (Berl) (2014) 0.77
Cannabis reward: biased towards the fairer sex? Br J Pharmacol (2007) 0.77
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives. Psychopharmacology (Berl) (2016) 0.75
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling. Behav Pharmacol (2016) 0.75
Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210. Biomol Ther (Seoul) (2015) 0.75
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory. Neuropsychopharmacology (2016) 0.75
Self-Administration of JWH-018 A Synthetic Cannabinoid in Experimentally Naïve Rats. J Alcohol Drug Depend (2015) 0.75
Behavioral Determinants of Cannabinoid Self-Administration in Old-World Monkeys. Neuropsychopharmacology (2017) 0.75
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. Br J Pharmacol (2013) 0.75
Screening Medications for the Treatment of Cannabis Use Disorder. Int Rev Neurobiol (2016) 0.75
Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Front Neurosci (2016) 0.75
Self-Administration of an Endogenous Cannabinoid 2-Arachidonoylglycerol in Experimentally Naïve Rats. J Alcohol Drug Depend (2015) 0.75
Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats. Front Behav Neurosci (2017) 0.75
Assessing the value of the zebrafish conditioned place preference model for predicting human abuse potential. J Pharmacol Exp Ther (2017) 0.75
Muscle regeneration by bone marrow-derived myogenic progenitors. Science (1998) 10.66
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
Dyslexia: cultural diversity and biological unity. Science (2001) 4.17
Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell (1997) 3.42
Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol (1999) 2.74
A cultural effect on brain function. Nat Neurosci (2000) 2.69
Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci (2008) 2.52
Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5. Development (1998) 2.22
Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J Cell Biol (1995) 2.19
Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci (2000) 2.13
In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci (1999) 2.12
Patterned ballistic movements triggered by a startle in healthy humans. J Physiol (1999) 2.04
Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat Commun (2011) 2.03
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci (2001) 1.78
Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. Hum Gene Ther (1999) 1.66
The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development. J Cell Biol (1991) 1.60
Uno, nessuno e centomila: searching for the identity of mesodermal progenitors. Exp Cell Res (1999) 1.56
Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci U S A (1985) 1.50
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br J Pharmacol (2007) 1.47
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res (2001) 1.46
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest (1998) 1.43
Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation. Cell Death Differ (2010) 1.35
'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther (2003) 1.35
Sleep deprivation in the rat: an animal model of mania. Eur Neuropsychopharmacol (1995) 1.25
Differential response of embryonic and fetal myoblasts to TGF beta: a possible regulatory mechanism of skeletal muscle histogenesis. Development (1994) 1.25
A population of myogenic cells derived from the mouse neural tube. Neuron (1994) 1.25
Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines. Cancer Res (1984) 1.19
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience (1998) 1.18
Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. J Pharmacol Exp Ther (1978) 1.17
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant (2007) 1.16
Differential response of satellite cells and embryonic myoblasts to a tumor promoter. Dev Biol (1983) 1.14
Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity. Cancer Res (2001) 1.12
Determination of methionine enkephalin in discrete regions of rat brain. Brain Res (1977) 1.12
Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis. Mech Dev (1999) 1.11
Neural control of early myogenic differentiation in cultures of mouse somites. Dev Biol (1986) 1.10
Localized epileptiform activity induced by murine CRF in rats. Epilepsia (1988) 1.10
Negative regulation of beta enolase gene transcription in embryonic muscle is dependent upon a zinc finger factor that binds to the G-rich box within the muscle-specific enhancer. J Biol Chem (1998) 1.09
Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur J Neurosci (2003) 1.08
Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death Differ (2008) 1.07
CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res (1999) 1.06
Transplacental delivery of the Wnt antagonist Frzb1 inhibits development of caudal paraxial mesoderm and skeletal myogenesis in mouse embryos. Development (1999) 1.04
Establishing myogenic identity during somitogenesis. Curr Opin Genet Dev (1997) 1.03
Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones. Br J Pharmacol (2010) 1.03
Acetylcholine receptor channels are present in undifferentiated satellite cells but not in embryonic myoblasts in culture. Dev Biol (1987) 1.03
Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. Proc Natl Acad Sci U S A (1998) 1.02
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum Gene Ther (1993) 1.01
Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy. Cell Death Dis (2010) 0.99
Detection of two endorphin-like peptides in nucleus caudatus. Neuropharmacology (1978) 0.98
Isolation and chemical characterization of a melanoma-associated proteoglycan antigen. Arch Biochem Biophys (1983) 0.98
Y-chromosome specific YCAII, DYS19 and YAP polymorphisms in human populations: a comparative study. Ann Hum Genet (1999) 0.97
In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells. Cell Differ (1980) 0.97
Rat brain enkephalins: distribution and biosynthesis. Adv Biochem Psychopharmacol (1978) 0.97
The expression of slow myosin during mammalian somitogenesis and limb bud differentiation. J Cell Biol (1988) 0.97
Benzodiazepine-induced voraciousness in cats and inhibition of amphetamine-anorexia. Life Sci (1976) 0.97
Signal transduction in T lymphocytes--a comparison of the data from space, the free fall machine and the random positioning machine. Adv Space Res (1999) 0.96
Vitamin A inhibits chondrogenesis but not myogenesis. Exp Cell Res (1980) 0.96
Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum. Brain Res (1979) 0.94
Emergence of TPA-resistant 'satellite' cells during muscle histogenesis of human limb. Exp Cell Res (1985) 0.92
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. Hum Gene Ther (1995) 0.92
Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats. Alcohol Clin Exp Res (1999) 0.92
The homeobox gene Arx is a novel positive regulator of embryonic myogenesis. Cell Death Differ (2007) 0.92
Skeletal myogenesis on highly orientated microfibrous polyesterurethane scaffolds. J Biomed Mater Res A (2008) 0.91
Development of 'revertant' myotubes in cultures of Rous sarcoma virus transformed avian myogenic cells. Differentiation (1983) 0.91
Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy. Neuroscience (2002) 0.91
Absence of MEF2 binding to the A/T-rich element in the muscle creatine kinase (MCK) enhancer correlates with lack of early expression of the MCK gene in embryonic mammalian muscle. Cell Growth Differ (1997) 0.91
Fidia and neuroscience. Nature (1993) 0.90
Characterization of enkephalin-like material extracted from sympathetic ganglia. Neuropharmacology (1978) 0.89
Neonatal screening of beta-thalassemias by thin layer isoelectric focusing. Am J Hematol (1982) 0.89
Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature (1977) 0.89
Neurobiological mechanisms of cannabinoid addiction. Mol Cell Endocrinol (2008) 0.89
Lactosaminoglycans and heparan sulfate are covalently bound to fibronectins synthesized by mouse stem teratocarcinoma cells. J Biol Chem (1983) 0.89
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol (1999) 0.88
Transformation by Rous sarcoma virus induces similar patterns of glycosaminoglycan synthesis in chick embryo skin fibroblasts and vertebral chondroblasts. J Biol Chem (1983) 0.88
Stress-induced sleep deprivation modifies corticotropin releasing factor (CRF) levels and CRF binding in rat brain and pituitary. Pharmacol Res (1997) 0.87
In vitro excitatory actions of corticotropin-releasing factor on rat colonic motility. J Auton Pharmacol (1998) 0.87
Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav (1995) 0.87
Necdin enhances muscle reconstitution of dystrophic muscle by vessel-associated progenitors, by promoting cell survival and myogenic differentiation. Cell Death Differ (2011) 0.87
Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav (1992) 0.87
Homosexual mounting behavior induced in male rats and rabbits by a tryptophan-free diet. Life Sci (1977) 0.86
L-selectin and SDF-1 enhance the migration of mouse and human cardiac mesoangioblasts. Cell Death Differ (2011) 0.86
TPA-induced inhibition of the expression of differentiative traits in cultured myotubes: dependence on protein synthesis. Differentiation (1982) 0.85
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis. Toxicol Lett (2001) 0.85
Interactions between enkephalinergic and other neuronal systems. Adv Biochem Psychopharmacol (1978) 0.85
Enkephalin in bovine adrenal gland: multiple molecular forms of [Met5]-enkephalin immunoreactive peptides. Neuropharmacology (1980) 0.85
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. FASEB J (2007) 0.84
TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. Exp Cell Res (1993) 0.84
Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice. Eur Neuropsychopharmacol (1998) 0.84
Paracrine stimulation of senescent satellite cell proliferation by factors released by muscle or myotubes from young mice. Mech Ageing Dev (1993) 0.84
Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs. Curr Drug Targets (2010) 0.84
Similar glycopeptides in normal chondroblasts and in Rous sarcoma virus-transformed fibroblasts. J Biol Chem (1982) 0.84